Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myeloma overexpressed 2 pseudogene (Myeov2-ps)
- Target
- Myeov2-ps
- Molecular classification
- Other (pseudogene; not a protein-coding gene)
01
Overview
Myeloma overexpressed 2 pseudogene (ENSG00000258802) is a non-protein-coding gene related by sequence similarity to the protein-coding gene Myeov2 (myeloma overexpressed 2), which is evolutionarily conserved and involved in the regulation of nucleolus integrity and stress response in plasma cells[3]. However, the pseudogene itself does not produce a functional protein and is not implicated as a drug target or therapeutic entity. While its parent gene, Myeov2, has been studied in the context of multiple myeloma, there is no evidence that the pseudogene plays a direct role in disease, serves as a biomarker, or is considered in drug development efforts[3].
- Other names
- Myeloma overexpressed 2 pseudogeneMyeov2-psENSG00000258802
02
Biological functions
Other (pseudogenes may play regulatory roles such as acting as non-coding RNAs or affecting gene expression, but specific functions for this pseudogene are not described in the literature)
03
Disease associations
Other (no established direct disease role; parent gene Myeov2 is implicated in multiple myeloma, but no evidence for disease involvement of the pseudogene variant)
Beyond the preview
Go deeper on Myeloma overexpressed 2 pseudogene (Myeov2-ps).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myeloma overexpressed 2 pseudogene (Myeov2-ps).